TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry | #o | #f |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
12/15/25 19:55 | 12/11/25 | CLYM | Climb Bio, Inc. | DE | Health | Drug | Pharmaceutical Preparations | 1 | 1 | P.dm | 755 | 2.40 | 0 | 315 | 3 | 11,294 | I | ||||||||||||||
12/10/25 16:42 | 12/8/25 | FULC | Fulcrum Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | 1 | 1 | S | -58,377 | 13.98 | 0 | -4,175 | 6,054 | I | |||||||||||||||
11/24/25 17:43 | 11/20/25 | SION | Sionna Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | 1 | 3 | S.m | -21,463 | 39.73 | 0 | -540 | 209 | I | |||||||||||||||
11/14/25 18:14 | 11/13/25 | WVE | Wave Life Sciences Ltd. | U0 | Health | Drug | Pharmaceutical Preparations | 1 | 1 | P | 7 | 6.69 | 0 | 1 | 0 | 18,232 | I | ||||||||||||||
11/12/25 16:26 | 11/7/25 | EVMN | Evommune, Inc. | DE | Health | Drug | Pharmaceutical Preparations | 1 | 1 | P.d | 20,000 | 16.00 | 0 | 1,250 | 784 | I | |||||||||||||||
10/30/25 18:40 | 10/28/25 | VOR | Vor Biopharma Inc. | Health | BioPrd | Biological Products, (No Diag | 1 | 4 | S.m | -33,715 | 28.03 | 0 | -1,203 | 1,401 | I | ||||||||||||||||
9/30/25 16:35 | 9/26/25 | PEPG | Pepgen Inc. | DE | Health | Drug | Pharmaceutical Preparations | 1 | 1 | P | 30,000 | 3.20 | 0 | 9,375 | 88 | 20,065 | I |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |